Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Recommendations for the optimal management of early and advanced urothelial carcinoma.

Castellano D, Carles J, Esteban E, Trigo JM, Climent MÁ, Maroto JP, del Muro XG, Font A, Paz-Ares L, Arranz JÁ, Bellmunt J.

Cancer Treat Rev. 2012 Aug;38(5):431-41. doi: 10.1016/j.ctrv.2011.10.004. Epub 2011 Nov 23. Review.

PMID:
22116017
2.

[European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].

Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.

Actas Urol Esp. 2012 Jan;36(1):2-14. doi: 10.1016/j.acuro.2011.09.001. Epub 2011 Oct 29. Spanish.

PMID:
22036956
3.

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS.

Urology. 2007 Jan;69(1 Suppl):62-79. Review.

PMID:
17280909
4.

[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.

Actas Urol Esp. 2010 Jan;34(1):51-62. Spanish.

PMID:
20223133
5.

Advanced bladder cancer in a young female: a case report.

Masuda A, Minakmi S, Usui Y, Arihara K, Nagata Y, Kawamura N.

Tokai J Exp Clin Med. 2001 Jul;26(2):39-43.

PMID:
11806441
6.

Diagnosis and management of superficial bladder cancer.

Amling CL.

Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. Review.

PMID:
11514784
7.

Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.

Oosterlinck W, Solsona E, Akaza H, Busch C, Goebell PJ, Malmström PU, Ozen H, Sved P.

Urology. 2005 Dec;66(6 Suppl 1):75-89. Review.

PMID:
16399417
8.

Update on chemotherapy for advanced bladder cancer.

Rosenberg JE, Carroll PR, Small EJ.

J Urol. 2005 Jul;174(1):14-20. Review.

PMID:
15947569
9.

Selection of treatment for muscle infiltrating transitional cell bladder cancer.

Whitmore WF.

Arch Esp Urol. 1990;43 Suppl 2:219-22. Review.

PMID:
2096783
10.

Diagnosis and treatment of bladder cancer.

Sharma S, Ksheersagar P, Sharma P.

Am Fam Physician. 2009 Oct 1;80(7):717-23. Review.

11.

Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.

Izawa JI, Chin JL, Winquist E.

Can J Urol. 2006 Jun;13 Suppl 3:48-53. Review.

PMID:
16818012
12.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
13.

Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.

Milowsky MI, Stadler WM, Bajorin DF.

BJU Int. 2008 Nov;102(9 Pt B):1339-44. doi: 10.1111/j.1464-410X.2008.07980.x. Review.

PMID:
19035902
14.

Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.

Coblentz TR, Mills SE, Theodorescu D.

Cancer. 2001 Apr 1;91(7):1284-90.

PMID:
11283928
15.

Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.

Calabrò F, Sternberg CN.

Eur Urol. 2009 Feb;55(2):348-58. doi: 10.1016/j.eururo.2008.10.016. Epub 2008 Oct 16. Review.

PMID:
18977070
16.

Importance of node dissection in relation to neoadjuvant and adjuvant therapy.

Huang WC, Bochner BH.

J Natl Compr Canc Netw. 2006 Nov;4(10):1019-26. Review.

PMID:
17112450
17.

Bladder cancer.

Gwynn ES, Clark PE.

Curr Opin Oncol. 2006 May;18(3):277-83. Review.

PMID:
16552241
18.

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology (EAU).

Eur Urol. 2011 Jun;59(6):1009-18. doi: 10.1016/j.eururo.2011.03.023. Epub 2011 Mar 23. Review.

PMID:
21454009
19.

Genetic and molecular markers of urothelial premalignancy and malignancy.

Cordon-Cardo C, Cote RJ, Sauter G.

Scand J Urol Nephrol Suppl. 2000;(205):82-93. Review.

PMID:
11144907
20.

Therapeutic approaches to bladder cancer: identifying targets and mechanisms.

Cote RJ, Datar RH.

Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S67-83. Review.

PMID:
12850529

Supplemental Content

Support Center